Your browser is no longer supported. Please, upgrade your browser.
A [NYSE]
Agilent Technologies, Inc.
IndexS&P 500 P/E51.33 EPS (ttm)2.98 Insider Own0.30% Shs Outstand304.00M Perf Week0.60%
Market Cap46.33B Forward P/E33.15 EPS next Y4.62 Insider Trans-20.01% Shs Float301.33M Perf Month3.67%
Income925.00M PEG4.75 EPS next Q0.99 Inst Own89.50% Short Float0.85% Perf Quarter14.66%
Sales5.82B P/S7.96 EPS this Y-31.60% Inst Trans0.35% Short Ratio1.53 Perf Half Y27.51%
Book/sh15.82 P/B9.69 EPS next Y11.62% ROA9.40% Target Price148.94 Perf Year59.73%
Cash/sh4.56 P/C33.57 EPS next 5Y10.80% ROE19.00% 52W Range94.53 - 153.60 Perf YTD29.32%
Dividend0.78 P/FCF45.24 EPS past 5Y12.00% ROI10.00% 52W High-0.20% Beta1.00
Dividend %0.51% Quick Ratio1.50 Sales past 5Y5.70% Gross Margin53.50% 52W Low62.18% ATR1.87
Employees16500 Current Ratio2.00 Sales Q/Q23.20% Oper. Margin19.70% RSI (14)68.08 Volatility1.28% 1.15%
OptionableYes Debt/Eq0.61 EPS Q/Q117.30% Profit Margin15.90% Rel Volume0.56 Prev Close153.23
ShortableYes LT Debt/Eq0.57 EarningsAug 17 AMC Payout24.40% Avg Volume1.68M Price153.30
Recom1.90 SMA202.29% SMA505.87% SMA20020.58% Volume828,005 Change0.05%
Mar-18-21Upgrade Citigroup Neutral → Buy $135 → $150
Feb-17-21Upgrade BofA Securities Neutral → Buy $147
Dec-02-20Initiated Goldman Buy $130
Nov-25-20Upgrade UBS Neutral → Buy $103 → $132
Nov-17-20Upgrade Cleveland Research Neutral → Buy
Nov-10-20Initiated KeyBanc Capital Markets Overweight $130
Sep-30-20Initiated Atlantic Equities Neutral $105
Aug-19-20Reiterated Wells Fargo Overweight $100 → $105
Aug-19-20Reiterated SVB Leerink Outperform $95 → $100
Aug-19-20Reiterated Stifel Hold $85 → $100
Aug-19-20Reiterated Robert W. Baird Outperform $87 → $104
Aug-19-20Reiterated Jefferies Buy $95 → $110
Aug-19-20Reiterated Citigroup Neutral $85 → $100
Aug-19-20Reiterated BofA Securities Neutral $99 → $103
Feb-24-20Downgrade Needham Buy → Hold
Jan-08-20Initiated Wells Fargo Overweight $100
Jan-07-20Initiated Citigroup Neutral $85
Nov-26-19Reiterated Needham Buy $92 → $85
Nov-15-19Initiated Stifel Hold
Oct-18-19Downgrade UBS Buy → Neutral $82
Aug-02-21 12:54PM  
12:10PM  
12:00PM  
11:27AM  
10:08AM  
09:32AM  
08:50AM  
Jul-30-21 12:02PM  
11:45AM  
11:42AM  
11:05AM  
11:05AM  
10:27AM  
10:00AM  
09:30AM  
Jul-29-21 11:59AM  
11:53AM  
11:30AM  
Jul-28-21 09:37AM  
08:00AM  
Jul-27-21 11:36AM  
10:58AM  
08:00AM  
Jul-26-21 11:45AM  
11:37AM  
Jul-22-21 11:00AM  
Jul-21-21 10:44AM  
08:00AM  
Jul-20-21 12:34PM  
08:30AM  
Jul-19-21 09:00AM  
Jul-15-21 10:41AM  
Jul-13-21 09:00AM  
Jul-09-21 11:09AM  
01:17AM  
Jul-05-21 12:00PM  
10:28AM  
Jul-01-21 09:00AM  
Jun-28-21 08:00AM  
Jun-24-21 11:30AM  
Jun-23-21 01:25PM  
10:15AM  
Jun-22-21 03:00AM  
Jun-18-21 11:01AM  
08:47AM  
Jun-17-21 11:30AM  
Jun-14-21 12:20PM  
08:00AM  
Jun-09-21 01:19AM  
Jun-04-21 02:18PM  
08:00AM  
Jun-03-21 12:00PM  
Jun-02-21 08:00AM  
Jun-01-21 08:00AM  
May-26-21 10:00AM  
08:27AM  
May-25-21 08:30PM  
05:20PM  
04:05PM  
May-20-21 01:37PM  
01:12PM  
May-19-21 04:05PM  
May-18-21 03:00PM  
08:30AM  
May-13-21 12:29PM  
09:44AM  
May-12-21 10:49AM  
May-11-21 01:53PM  
11:55AM  
11:00AM  
May-10-21 02:44PM  
12:01PM  
10:22AM  
10:09AM  
09:58AM  
08:42AM  
06:42AM  
06:38AM  
May-07-21 04:11PM  
01:08PM  
01:06PM  
01:03PM  
10:48AM  
10:07AM  
10:02AM  
09:59AM  
09:44AM  
09:00AM  
08:24AM  
07:32AM  
May-06-21 03:55PM  
03:51PM  
12:42PM  
12:04PM  
12:01PM  
12:00PM  
11:28AM  
11:12AM  
11:06AM  
10:46AM  
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass and optical emission spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software, information management, and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment to produce synthesized oligonucleotide. It also offers immunohistochemistry, in situ hybridization, and hematoxylin and eosin staining and special staining; instruments, consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. It has collaboration agreement with SGS AXYS. The company was incorporated in 1999 and is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grau DominiqueSenior Vice PresidentJun 17Option Exercise40.801,96880,29483,388Jun 21 05:18 PM
Grau DominiqueSenior Vice PresidentJun 17Sale145.101,968285,56381,420Jun 21 05:18 PM
Grau DominiqueSenior Vice PresidentJun 16Option Exercise40.803,487142,27084,907Jun 17 12:16 PM
Grau DominiqueSenior Vice PresidentJun 16Sale145.013,487505,65381,420Jun 17 12:16 PM
Grau DominiqueSenior Vice PresidentJun 15Option Exercise40.803,578145,98284,998Jun 17 12:16 PM
Grau DominiqueSenior Vice PresidentJun 15Sale145.033,578518,91781,420Jun 17 12:16 PM
Ancher-Jensen HenrikSr Vice PresidentJun 14Option Exercise40.8024,8411,013,513120,633Jun 17 12:13 PM
Ancher-Jensen HenrikSr Vice PresidentJun 14Sale143.6643,7316,282,52776,902Jun 17 12:13 PM
Thaysen JacobSr. Vice PresidentJun 10Sale142.9016,2892,327,69883,423Jun 14 12:18 PM
MCDONNELL PADRAIGSr. Vice PresidentMay 28Sale138.421,000138,42016,916Jun 01 06:19 PM
Tang MichaelSVP, General Counsel, and Sec.May 27Sale136.1513,4651,833,35139,579Jun 01 06:18 PM
Tang MichaelSVP, General Counsel, and Sec.Apr 23Sale137.0050068,50053,030Apr 26 05:59 PM
McMullen Michael R.CEO and PresidentApr 22Sale135.009,0531,222,155261,105Apr 26 05:58 PM
McMullen Michael R.CEO and PresidentApr 13Sale132.508,9661,187,995270,158Apr 15 06:47 PM
McMullen Michael R.CEO and PresidentApr 08Sale130.2615,0951,966,275279,124Apr 12 07:01 PM
Gonsalves RodneyV.P., Corporate ControllerFeb 22Sale124.175,000620,85041,229Feb 24 05:54 PM
Grau DominiqueSenior Vice PresidentFeb 17Option Exercise40.809,034368,58795,071Feb 18 06:31 PM
Tang MichaelSVP, General Counsel, and Sec.Feb 17Sale133.0050066,50053,530Feb 18 06:48 PM
Grau DominiqueSenior Vice PresidentFeb 17Sale135.1113,7451,857,08781,326Feb 18 06:31 PM
Grau DominiqueSenior Vice PresidentFeb 16Sale130.146,041786,19486,037Feb 18 06:31 PM
Tang MichaelSVP, General Counsel, and Sec.Feb 16Sale129.3150064,65554,030Feb 18 06:48 PM
McMullen Michael R.CEO and PresidentFeb 16Sale130.0020,7662,699,580294,219Feb 18 06:33 PM
McMullen Michael R.CEO and PresidentFeb 02Sale123.7441,9785,194,232314,985Feb 03 01:28 PM
McMullen Michael R.CEO and PresidentFeb 01Sale120.2621,2122,550,955356,963Feb 03 01:28 PM
Tang MichaelSVP, General Counsel, and Sec.Jan 14Sale127.2750063,63554,880Jan 19 05:01 PM
McMullen Michael R.CEO and PresidentDec 01Sale115.6385,8429,925,910415,347Dec 02 08:17 PM
KOH BOON HWEEDirectorNov 30Sale114.5120,0002,290,20068,051Dec 02 08:16 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 09Sale116.162,222258,10856,807Nov 12 01:31 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 05Sale111.001,111123,32159,029Nov 09 02:33 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 04Sale108.501,111120,54460,140Nov 05 03:45 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 03Sale106.431,111118,24461,251Nov 05 03:45 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 02Sale103.521,111115,01162,362Nov 03 03:41 PM
Tang MichaelSVP, General Counsel, and Sec.Oct 30Sale101.773,333339,19963,473Nov 03 03:41 PM
Grau DominiqueSenior Vice PresidentOct 09Option Exercise39.126,485253,693104,154Oct 13 02:32 PM
Grau DominiqueSenior Vice PresidentOct 09Sale105.006,485680,92597,669Oct 13 02:32 PM
Grau DominiqueSenior Vice PresidentAug 31Option Exercise39.126,485253,693104,154Sep 01 05:19 PM
Grau DominiqueSenior Vice PresidentAug 31Sale100.006,485648,50097,669Sep 01 05:19 PM
Gonsalves RodneyV.P., Corporate ControllerAug 25Option Exercise40.806,191252,59348,334Aug 27 12:15 PM
Gonsalves RodneyV.P., Corporate ControllerAug 25Sale98.176,191607,75242,143Aug 27 12:15 PM